VALCYTE Reviews (VALGANCICLOVIR HYDROCHLORIDE)

Average Rating: 2.5 (2 Ratings)

Filter Results

Compare VALCYTE with similar:

 Type: Rx Drug

  

VALCYTE  (VALGANCICLOVIR HYDROCHLORIDE):  Valganciclovir is an anti-viral drug. It is changed in the body to the active form of the drug called ganciclovir. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Valganciclovir works by slowing the growth of the CMV virus. It helps prevent the spread of infection to other areas of the body. Valganciclovir is also used to treat CMV retinitis in people with advanced HIV disease (AIDS). This medication helps control CMV retinitis and decrease the risk of blindness. Valganciclovir is not a cure for CMV disease. Some people may have worsening CMV retinitis even with treatment. Therefore, it is important to have your eyes checked regularly by your doctor.   FDA Approval Date: 2009-08-28 (Sources: U.S. Centers for Medicare Services, FDA)

  

Results are sorted by Date added.

Key to Ratings: 1=LOW (I would not recommend taking this medicine.)
5=HIGH (this medicine cured me or helped me a great deal.)

Page: 1


RATING  REASONSIDE EFFECTS FOR VALCYTECOMMENTSSEXAGEDURATION/
DOSAGE
DATE ADDED
 
 1  Had to go off after only 4 days Unbearable neurological side effects immense fatigue brain fog listlessness depression. Increase pain upset stomach F 62 0 days
2/21/2022
 4  Hhv6 Nausea, headaches, loss of appetite, weight loss,fatigue, malaise M 30 2 years
450 mg 3X day
1/9/2011
  

VALCYTE  (VALGANCICLOVIR HYDROCHLORIDE):  Valganciclovir is an anti-viral drug. It is changed in the body to the active form of the drug called ganciclovir. It is used to prevent disease caused by a virus called cytomegalovirus (CMV) in people who have received organ transplants. CMV disease can lead to serious infections in the body, including an infection in the eye, called CMV retinitis, that can cause blindness. Valganciclovir works by slowing the growth of the CMV virus. It helps prevent the spread of infection to other areas of the body. Valganciclovir is also used to treat CMV retinitis in people with advanced HIV disease (AIDS). This medication helps control CMV retinitis and decrease the risk of blindness. Valganciclovir is not a cure for CMV disease. Some people may have worsening CMV retinitis even with treatment. Therefore, it is important to have your eyes checked regularly by your doctor.   FDA Approval Date: 2009-08-28 (Sources: U.S. Centers for Medicare Services, FDA)

     

BACK TO TOP